Nvidia, AMD and Intel Invest in Startup Bringing Light to Chips
December 11, 2024 | Company
Ayar Labs Inc., which specializes in using light to transfer data between chips, scored investment from the thre...
Read more >
EMA authorizes Phase 3 clinical trial for denovoSkin™
December 3, 2024 | Company
CUTISS has received authorization from the European Medicines Agency (EMA) to commence the Phase 3 clinical tria...
Read more >
Immunophotonics Announces 1st Patient Dosed in a Randomised Phase 2 Study at the University of Louisville
August 15, 2024 | Company
Immunophotonics, Inc., in collaboration with Dr. Robert CG Martin II, M.D, PhD, FACS, who serves as the Principa...
Read more >
SkyCell closes US$116 million Series D
June 25, 2024 | Company
SkyCell has successfully closed a $116 million Series D funding round. This investment will be used for the cont...
Read more >
CUTISS announces first closing of CHF 25M in Series C funding round
May 17, 2024 | Company
CUTISS is glad to announce the first closing of CHF 25 million in its Series C funding round. This milestone dem...
Read more >
CUTISS continues collaboration with Santobono Hospital in Naples
May 16, 2024 | Company
A significant milestone in pediatric burn care in Italy has been achieved with the inauguration of the new pedia...
Read more >